The expanding spectrum of EBV+ lymphomas.
In this issue of Blood, Nicolae et al at the National Cancer Institute describe a series of Epstein-Barr virus–positive (EBV+) diffuse large B-cell lymphomas (DLBCLs) in young patients (median age 23 years) without known immunodeficiency.